A batch of the Johnson & Johnson COVID-19 vaccine failed quality standard checks, according to officials.
The company announced that an ingredient made by Emergent BioSolutions – one of about 10 companies that Johnson & Johnson is using to speed up manufacturing of its recently approved vaccine – did not meet quality standards.
The company says it will still be able to provide 100 million doses of the vaccine by the end of June.
Federal officials say they are confident of vaccination goals, even with the issue surrounding the J&J vaccine.
Make FL1 part of your day.
Local reporting. Useful updates. More ways to stay close to your community.
Go ad-free
Support independent local reporting and enjoy FL1 without display ads.
$4.99 / month
Become a member →Cancel anytime. Third-party media players may contain ads.Get the daily briefing
Start your morning with the headlines that matter across the Finger Lakes.
Find more FL1 on Google
Choose FingerLakes1.com as a preferred source to see more of our reporting in your Google news results.






